722 followers
Switch study: a randomised-controlled trial of switching to alternative TNF-inhibitor drug, abatacept or rituximab. http://t.co/LzR7QdHuQ1
Switch study: a randomised-controlled trial of switching to alternative TNF-inhibitor drug, abatacept or rituximab. http://t.co/LzR7QdHuQ1
Switch study: a randomised-controlled trial of switching to alternative TNF-inhibitor drug, abatacept or rituximab. http://t.co/LzR7QdHuQ1
Background: Rheumatoid Arthritis (RA) is one of the most common autoimmune diseases, affecting approximately 1%... http://t.co/KGoaEwZhZ8